Young-onset Alzheimer's picks up damaging pace
Bruce Vincent has a form of Alzheimer's that strikes at a young age. At only 49, the disease is picking up its brain-robbing pace. (Video by Scott LaPierre / Globe Staff)
Testing of several potential Alzheimer’s medications has yielded recent disappointments, but important lessons can be gleaned from those failures, says a top Boston researcher.
An international team of researchers has convinced federal regulators to relax rules that had barred many Alzheimer’s patients from clinical trials of a medication designed to halt the disease.
Researchers from Boston University School of Medicine are part of an international collaboration to discover and map all of the genes linked to Alzheimer’s disease in an effort to improve treatments.
This is the story in photos of how Bruce Vincent and his family have been coping with the disease over time.
The Alzheimer’s Association released a full report this year outlining facts and figures about the disease in the United States. It provides state-by-state breakdowns, information about associated risks, data on different kinds of treatment and care, and resources for early diagnosis and detection.
As Ebola spreads beyond West Africa, I find myself thinking about the early days of the AIDS epidemic.
A new study could help patients and their doctors navigate the difficult decision of how aggressively to treat Type 2 diabetes.
Medical ethicists warn that US medical facilities and states have few plans in place to allocate limited supplies.